Literature DB >> 4670698

Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora.

G P Bodey.   

Abstract

Eight patients in protected environment units received by the oral route a solution of gentamicin and vancomycin which completely suppressed all 78 strains of bacteria originally present in their stools. However, when the solution was discontinued bacteria were cultured again from the stools of every patient. Twenty-nine of the 42 strains cultured at this time were also cultured from pretreatment specimens. Oral absorbable antibiotics were given to six of these patients, but they eliminated only 10 of the 32 strains cultured from their stools. Seven of the 16 strains which persisted became resistant to the oral absorbable antibiotic. To achieve maximum effect, oral nonabsorbable antibiotic regimens must be continued as long as the patient remains in a protected environment unit.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4670698      PMCID: PMC444219          DOI: 10.1128/AAC.1.4.343

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.

Authors:  H D Preisler; I M Goldstein; E S Henderson
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

2.  Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results.

Authors:  G P Bodey; J Hart; E J Freireich; E Frei
Journal:  Cancer       Date:  1968-11       Impact factor: 6.860

3.  Protected environment for cancer patients. Effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy.

Authors:  G P Bodey; J Loftis; E Bowen
Journal:  Arch Intern Med       Date:  1968-07

4.  Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

Authors:  G P Bodey; E A Gehan; E J Freireich; E Frei
Journal:  Am J Med Sci       Date:  1971-09       Impact factor: 2.378

5.  Sterile food service for patients in protected environments.

Authors:  P Watson; G P Bodey
Journal:  J Am Diet Assoc       Date:  1970-06

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Studies of patients in a laminar air flow unit.

Authors:  G P Bodey; E J Freireich; E Frei
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

8.  Patient protection in cancer chemotherapy.

Authors:  S A Schwartz; S Perry
Journal:  JAMA       Date:  1966-08-22       Impact factor: 56.272

9.  Microbiological evaluation of protected environments during patient occupancy.

Authors:  G P Bodey; D Johnston
Journal:  Appl Microbiol       Date:  1971-11
  9 in total
  7 in total

1.  Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia.

Authors:  M T Hargadon; V M Young; S C Schimpff; J C Wade; G E Minah
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

2.  Increase of the intestinal absorption of gentamicin and amikacin by a nonionic surfactant.

Authors:  A Rubinstein; E Rubinstein; E Toitou; M Donbrow
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

3.  Preventing infection in neutropenic cancer patients.

Authors:  S M Beutler; N M Barth; A S Bayer
Journal:  West J Med       Date:  1983-05

4.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

5.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients.

Authors:  J F Bender; S C Schimpff; V M Young; C L Fortner; M D Brouillet; L J Love; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.

Authors:  J R Wingard; J Dick; P Charache; R Saral
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.